Ginseng Compounds: an Update on Their Molecular Mechanisms and Medical Applications

Overview

Journal Curr Vasc Pharmacol

Publisher Bentham Science Publishers

Date 2009 Jul 16

PMID 19601854

Citations 254

Authors

Jian-Ming Lu

Qizhi Yao

Changyi Chen

Affiliations

Soon will be listed here.

Abstract

Ginseng is one of the most widely used herbal medicines and is reported to have a wide range of therapeutic and pharmacological applications. Ginsenosides, the major pharmacologically active ingredients of ginseng, appear to be responsible for most of the activities of ginseng including vasorelaxation, antioxidation, anti-inflammation and anti-cancer. Approximately 40 ginsenoside compounds have been identified. Researchers now focus on using purified individual ginsenoside to reveal the specific mechanism of functions of ginseng instead of using whole ginseng root extracts. Individual ginsenosides may have different effects in pharmacology and mechanisms due to their different chemical structures. Among them the most commonly studied ginsenosides are Rb1, Rg1, Rg3, Re, Rd and Rh1. The molecular mechanisms and medical applications of ginsenosides have attracted much attention and hundreds of papers have been published in the last few years. The general purpose of this update is to provide information of recently described effects of ginsenosides on antioxidation, vascular system, signal transduction pathways and interaction with receptors. Their therapeutic applications in animal models and humans as well as the pharmacokinetics and toxicity of ginsenosides are also discussed in this review. This review concludes with some thoughts for future directions in the further development of ginseng compounds as effective therapeutic agents.

Citing Articles

Korean Red Ginseng relieves the inflammation and oxidative stress induced by pseudo-typed SARS-CoV-2.

Kim H, Oh Y, Moon S, Oh J, Kim J, Lee S J Ginseng Res. 2025; 49(2):166-178.

PMID: 40061481 PMC: 11889375. DOI: 10.1016/j.jgr.2024.11.004.

The protective effect of 20(S)-ginsenoside Rg3 on the human retinal pigment epithelial cells against hydrogen peroxide-induced oxidative stress.

Kim B, Kim K, Kim J, Jang H, Min H Food Sci Biotechnol. 2024; 33(15):3607-3616.

PMID: 39493394 PMC: 11525376. DOI: 10.1007/s10068-024-01617-w.

Investigating the protective properties of Panax ginseng and its constituents against biotoxins and metal toxicity: a mechanistic review.

Rameshrad M, Memariani Z, Naraki K, Hosseinzadeh H Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1215-1242.

PMID: 39287674 DOI: 10.1007/s00210-024-03410-2.

Monoclonal antibody-based enzyme-linked immunosorbent assay for quantification of majonoside R2 as an authentication marker for Nngoc Linh and Lai Chau ginsengs.

Chaingam J, Van Huy L, Noguchi K, Nuntawong P, Vimolmangkang S, Yodsurang V J Ginseng Res. 2024; 48(5):474-480.

PMID: 39263304 PMC: 11385409. DOI: 10.1016/j.jgr.2024.05.004.

The Search for Drugs Derived from Natural Products for Infection Treatment in the Last 20 Years - A Systematic Review.

Marques-Santos F, Xavier Faria R, Amendoeira M Curr Top Med Chem. 2024; 24(22):1960-1999.

PMID: 38952156 DOI: 10.2174/0115680266299409240606062235.

References

Lau W, Chan R, Guo D, Wong M . Ginsenoside Rg1 exerts estrogen-like activities via ligand-independent activation of ERalpha pathway. J Steroid Biochem Mol Biol. 2007; 108(1-2):64-71. DOI: 10.1016/j.jsbmb.2007.06.005. View

Hasegawa H, MATSUMIYA S, Uchiyama M, Kurokawa T, Inouye Y, Kasai R . Inhibitory effect of some triterpenoid saponins on glucose transport in tumor cells and its application to in vitro cytotoxic and antiviral activities. Planta Med. 1994; 60(3):240-3. DOI: 10.1055/s-2006-959467. View

Benishin C, Lee R, Wang L, Liu H . Effects of ginsenoside Rb1 on central cholinergic metabolism. Pharmacology. 1991; 42(4):223-9. DOI: 10.1159/000138801. View

Cui X, Sakaguchi T, Shirai Y, Hatakeyama K . Orally administered Panax ginseng extract decreases platelet adhesiveness in 66% hepatectomized rats. Am J Chin Med. 1999; 27(2):251-6. DOI: 10.1142/S0192415X99000288. View

Vuksan V, Sievenpiper J, Xu Z, Wong E, Jenkins A, Leiter L . Konjac-Mannan and American ginsing: emerging alternative therapies for type 2 diabetes mellitus. J Am Coll Nutr. 2001; 20(5 Suppl):370S-380S; discussion 381S-383S. DOI: 10.1080/07315724.2001.10719170. View

Xue J, Liu Z, Hu J, Chen H, Zhang J, Chen N . Ginsenoside Rb1 promotes neurotransmitter release by modulating phosphorylation of synapsins through a cAMP-dependent protein kinase pathway. Brain Res. 2006; 1106(1):91-98. DOI: 10.1016/j.brainres.2006.05.106. View

Nah S, Kim D, Rhim H . Ginsenosides: are any of them candidates for drugs acting on the central nervous system?. CNS Drug Rev. 2007; 13(4):381-404. PMC: 6494168. DOI: 10.1111/j.1527-3458.2007.00023.x. View

Liu P, Xu Y, Yin H, Wang J, Chen K, Li Y . Developmental toxicity research of ginsenoside Rb1 using a whole mouse embryo culture model. Birth Defects Res B Dev Reprod Toxicol. 2005; 74(2):207-9. DOI: 10.1002/bdrb.20038. View

Wang W, Zhao Y, Rayburn E, Hill D, Wang H, Zhang R . In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol. 2006; 59(5):589-601. DOI: 10.1007/s00280-006-0300-z. View

10.

Hofseth L, Wargovich M . Inflammation, cancer, and targets of ginseng. J Nutr. 2006; 137(1 Suppl):183S-185S. DOI: 10.1093/jn/137.1.183S. View

11.

Borchers A, Keen C, Stern J, Gershwin M . Inflammation and Native American medicine: the role of botanicals. Am J Clin Nutr. 2000; 72(2):339-47. DOI: 10.1093/ajcn/72.2.339. View

12.

Caron M, Hotsko A, Robertson S, Mandybur L, Kluger J, White C . Electrocardiographic and hemodynamic effects of Panax ginseng. Ann Pharmacother. 2002; 36(5):758-63. DOI: 10.1345/aph.1A411. View

13.

Choi K, Kim M, Ryu J, Choi C . Ginsenosides compound K and Rh(2) inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB and JNK pathways in human astroglial cells. Neurosci Lett. 2007; 421(1):37-41. DOI: 10.1016/j.neulet.2007.05.017. View

14.

Liu C, Xiao P . Recent advances on ginseng research in China. J Ethnopharmacol. 1992; 36(1):27-38. DOI: 10.1016/0378-8741(92)90057-x. View

15.

Seo J, Lee J, Kim N, Her E, Chang S, Ko N . Effect of a fermented ginseng extract, BST204, on the expression of cyclooxygenase-2 in murine macrophages. Int Immunopharmacol. 2005; 5(5):929-36. DOI: 10.1016/j.intimp.2005.01.008. View

16.

Furukawa T, Bai C, Kaihara A, Ozaki E, Kawano T, Nakaya Y . Ginsenoside Re, a main phytosterol of Panax ginseng, activates cardiac potassium channels via a nongenomic pathway of sex hormones. Mol Pharmacol. 2006; 70(6):1916-24. DOI: 10.1124/mol.106.028134. View

17.

Wu C, Tsai B, Hsieh W, Chang G, Mao S, Chang W . The preventive effects of G115 on balloon injury-induced neointima formation in rats. Life Sci. 2002; 70(6):669-79. DOI: 10.1016/s0024-3205(01)01442-4. View

18.

Chang Y, Huang W, Tien L, Wang S . Ginsenosides Rg1 and Rb1 enhance glutamate release through activation of protein kinase A in rat cerebrocortical nerve terminals (synaptosomes). Eur J Pharmacol. 2007; 578(1):28-36. DOI: 10.1016/j.ejphar.2007.09.023. View

19.

Leung K, Cheung L, Pon Y, Wong R, Mak N, Fan T . Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptor. Br J Pharmacol. 2007; 152(2):207-15. PMC: 1978254. DOI: 10.1038/sj.bjp.0707359. View

20.

Barnes P, Powell-Griner E, McFann K, Nahin R . Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004; (343):1-19. View